Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 EUR | -5.62% | -5.41% | -22.79% |
Mar. 15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
Sales 2022 | 1.9M 2.06M | Sales 2023 | 5.09M 5.52M | Capitalization | 9.01M 9.78M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | 2M 2.17M | EV / Sales 2022 | 2.47 x |
Net cash position 2022 | 421K 457K | Net cash position 2023 | 634K 688K | EV / Sales 2023 | 1.65 x |
P/E ratio 2022 |
14
x | P/E ratio 2023 |
3.28
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.51% |
1 day | -5.62% | ||
1 week | -5.41% | ||
Current month | -19.69% | ||
1 month | -25.53% | ||
3 months | -23.64% | ||
6 months | -12.50% | ||
Current year | -22.79% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 94-12-31 | |
Patrice Coffe
DFI | Director of Finance/CFO | 55 | 08-06-30 |
Chief Tech/Sci/R&D Officer | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jean-Luc Rivière
BRD | Director/Board Member | - | 12-06-25 |
Chief Executive Officer | 50 | 94-12-31 | |
Patrice Coffe
DFI | Director of Finance/CFO | 55 | 08-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.1 | -5.62% | 31,666 |
24-05-23 | 2.225 | -1.98% | 16,058 |
24-05-22 | 2.27 | -0.44% | 2,064 |
24-05-21 | 2.28 | +0.66% | 17,145 |
24-05-20 | 2.265 | +2.03% | 28,225 |
Real-time Euronext Paris, May 24, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-22.79% | 7.55M | |
-14.23% | 189B | |
+1.48% | 168B | |
+4.49% | 157B | |
+6.84% | 102B | |
+37.66% | 85.01B | |
+13.18% | 83.75B | |
-5.04% | 73.04B | |
-21.53% | 52.32B | |
-8.25% | 43.86B |
- Stock Market
- Equities
- ALKLA Stock